Fact CheckerSign in

NCT05972694Completed

Effect of Grapes in Inflammatory Bowel Disease

The Effect of Grapes in Inflammatory Bowel Disease

Source: ClinicalTrials.gov · Last updated 5 Mar 2026

Brief summary (registry, in English)

The overall objective of this pilot intervention study is to determine the impact of grape powder (46g/day freeze dried whole grape powder provided by the California Table Grape Commission) on the gut microbiotacomposition in adult patients with the IBD subtype Crohn's disease (CD).

Status (registry)
Completed
Study type
Interventional
Enrollment
21 (actual)
First submitted
24 Jul 2023
Start date
16 Sept 2024
Primary completion date
1 Aug 2025
Lead sponsor
Case Western Reserve University
NCT number
NCT05972694

What you commit to

  • Study type: Interventional
  • Participants enrolled: 21
  • From 16 Sept 2024 to the primary completion date, 1 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Known drug abuse.
  • Change in IBD medication within past 4 weeks.
  • No probiotic or antibiotic use for the previous 14 days

Other illness

  • Short bowel syndrome.
  • Individuals who lack consent capacity, including the mentally ill, prisoners, cognitively impaired participants, dementia patients.
  • Known parasitic disease of the digestive system.
  • Other conditions that would be a contraindication to consumption of the study diets or preclude the participant from completing the study.
  • History of \<1 natural bowel movements per day.
  • Known berry or grape allergy

Other

  • Hospitalized patients.
  • Symptomatic intestinal stricture.
  • Presence of an ostomy.
  • Well-founded doubt about the patients cooperation.
  • Existing pregnancy or lactation.
  • Unable to access to technology that permits the daily completion of study related activities.
  • Body mass Index \<16 kg/m or ≥35.
  • Documented C.difficile colitis within four weeks of screening.

Who the study is looking for

  • Documented diagnosis of Crohns disease. CD outpatients in remission
  • Harvey Bradshaw-index in remission (\<6 score)
  • Capable of providing consent to participate.
  • Able to complete daily surveys and take oral nutrition
  • Able to record daily meal intake

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospitals Cleveland Medical Center*
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.